Equities

iSpecimen Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ISPC:NAQ

iSpecimen Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.3184
  • Today's Change0.009 / 2.78%
  • Shares traded798.78k
  • 1 Year change-83.33%
  • Beta1.8453
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

  • Revenue in USD (TTM)3.35m
  • Net income in USD-11.53m
  • Incorporated2009
  • Employees24.00
  • Location
    iSpecimen Inc8 Cabot Road, Suite 1800WOBURN 08101United StatesUSA
  • Phone+1 (781) 301-6700
  • Fax+1 (302) 655-5049
  • Websitehttps://www.ispecimen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
iEntertainment Network Inc1.30m-1.76m2.62m18.00------2.01-0.0638-0.06070.0399-0.00230.9478--7.8372,166.66-123.90-123.52-516.90-306.8661.3561.12-130.72-95.07---246.20-----76.50-23.1566.41---13.22--
Strainsforpains Inc0.00-390.71k2.64m0.00---------0.8747-0.87470.00-5.100.00-------3,555.14-990.82------------------------6.03------
ModuLink Inc60.53k-122.33k2.78m----0.2597--45.91-0.0098-0.00980.00490.00270.1622-------32.78---44.12--68.43---202.10-----2.230.9375---38.82---69.78------
Dogecoin Cash Inc721.55k-1.41m2.78m1.00------3.85-0.0107-0.01070.0051-0.01110.3625-------427.41-66.25---583.3763.3662.43-1,178.98-115.10---5.941.13---31.62-7.10-24.29------
AGM Group Holdings Inc48.53m19.10m2.86m10.000.04450.08180.56350.05932.6235.1552.3017.730.7182--3.094,852,674.0028.277.3495.2227.1115.4517.2939.367.641.61--0.00---53.40149.72-70.15------
Webuy Global Ltd39.27m-11.37m2.87m174.00--3.35--0.073-14.10-14.1049.840.37921.77122.014.98225,690.00-51.85---239.57--7.20---29.34--0.8809-11.450.7116---5.48---28.57------
Signing Day Sports Inc366.35k-6.09m2.91m6.00------7.93-5.47-5.470.1453-0.01730.3356--18.9761,058.33-557.74------81.53---1,662.14-----24.79----100.13---59.29------
Universal New Energy Holding Group Inc0.00-241.85k2.91m2.00--21.86-----8.42-8.420.000.00660.00----0.00-1,676.60-178.21-2,439.23-402.20------------0.00------44.53------
Totaligent Inc2.25k-603.41k2.96m--------1,313.52-0.0029-0.00290.00001-0.00960.0029-------58.10------742.67---20,008.45-----------39.25---135.53------
iSpecimen Inc3.35m-11.53m3.03m24.00--0.9852--0.9029-6.95-6.951.140.31450.3309--2.44139,697.90-113.84-53.23-278.07-109.3221.2951.54-343.99-96.97---77.300.00---6.4216.67-12.60---14.23--
Xiao-I Corp (ADR)48.88m-29.13m3.27m162.00------0.067-2.27-2.274.75--0.5752256.280.9132301,712.70-34.60------68.48---60.15--0.7068-9.884.20--18.84--45.18------
RoyaLand Company Ltd-100.00bn-100.00bn3.59m------------------------------------------------------23.92------
Visium Technologies Inc0.00-2.11m3.63m5.00---------0.007-0.0070.00-0.01450.00----0.00-25,293.84-4,182.31-----------64,391.60---3.55--------53.37------
Data as of Feb 12 2026. Currency figures normalised to iSpecimen Inc's reporting currency: US Dollar USD

Institutional shareholders

3.57%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 30 Sep 2025153.46k1.57%
Virtu Americas LLCas of 30 Sep 202563.26k0.65%
Geode Capital Management LLCas of 30 Sep 202541.69k0.43%
Scientech Research LLCas of 30 Sep 202529.49k0.30%
Vanguard Fiduciary Trust Co.as of 31 Dec 202528.17k0.29%
Jane Street Capital LLCas of 30 Sep 202520.26k0.21%
UBS Securities LLCas of 31 Dec 20256.45k0.07%
BlackRock Fund Advisorsas of 30 Sep 20252.83k0.03%
Tower Research Capital LLCas of 30 Sep 20252.36k0.02%
The Vanguard Group, Inc.as of 31 Dec 20251.24k0.01%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.